Patents by Inventor Wibke Deisting

Wibke Deisting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY CONSTRUCTS FOR CD70 AND CD3
    Publication number: 20210284748
    Abstract: The present invention relates to a bispecific antibody construct comprising a first binding domain which binds to human CD70 on the surface of a target cell and a second binding domain which binds to human CD3 on the surface of a T cell. Moreover, the invention provides a polynucleotide encoding the antibody construct, a vector comprising said polynucleotide and a host cell transformed or transfected with said polynucleotide or vector. Furthermore, the invention provides a process for the production of the antibody construct of the invention, a medical use of said antibody construct and a kit comprising said antibody construct.
    Type: Application
    Filed: October 29, 2020
    Publication date: September 16, 2021
    Inventors: Tobias Raum, Claudia Blümel, Wibke Deisting, Patrick Hoffmann, Ralf Lutterbüse, Elisabeth Nahrwold, Olivier Nolan-Stevaux, Marc Panzer
  • Antibody constructs for CD70 and CD3
    Patent number: 10851170
    Abstract: The present invention relates to a bispecific antibody construct comprising a first binding domain which binds to human CD70 on the surface of a target cell and a second binding domain which binds to human CD3 on the surface of a T cell. Moreover, the invention provides a polynucleotide encoding the antibody construct, a vector comprising said polynucleotide and a host cell transformed or transfected with said polynucleotide or vector. Furthermore, the invention provides a process for the production of the antibody construct of the invention, a medical use of said antibody construct and a kit comprising said antibody construct.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: December 1, 2020
    Assignees: AMGEN RESEARCH (MUNICH) GMBH, AMGEN INC.
    Inventors: Tobias Raum, Claudia Blümel, Wibke Deisting, Patrick Hoffmann, Ralf Lutterbüse, Elisabeth Nahrwold, Olivier Nolan-Stevaux, Marc Panzer
  • ANTIBODY CONSTRUCTS FOR CD70 AND CD3
    Publication number: 20170129961
    Abstract: The present invention relates to a bispecific antibody construct comprising a first binding domain which binds to human CD70 on the surface of a target cell and a second binding domain which binds to human CD3 on the surface of a T cell. Moreover, the invention provides a polynucleotide encoding the antibody construct, a vector comprising said polynucleotide and a host cell transformed or transfected with said polynucleotide or vector. Furthermore, the invention provides a process for the production of the antibody construct of the invention, a medical use of said antibody construct and a kit comprising said antibody construct.
    Type: Application
    Filed: August 1, 2016
    Publication date: May 11, 2017
    Inventors: Tobias Raum, Claudia Blümel, Wibke Deisting, Patrick Hoffmann, Ralf Lutterbüse, Elisabeth Nahrwold, Olivier Nolan-Stevaux, Marc Panzer